Augment Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Augment Therapeutics Private Limited

Augment Therapeutics Private Limited, a active private limited company, was established on 06 April 2017 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U74999TG2017PTC116352. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Its leadership includes Apparao Satyam (Whole-Time Director), Veeraveni Baddireddi (Managing Director). Past directors included Apparao Satyam, Veeraveni Baddireddi. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Villa No. 03, Greenspace Emerald, Puppalguda Bh Sri Mahalaxmi Temple, Puppalguda-Nars, Ingi Rd, Hyderabad, Telangana, 500089.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2017PTC116352

  • Registration Number

    116352

  • Incorporation Date

    06 April 2017

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -30.37%
  • Ebitda **** -38.76%
  • Net Worth -10.39%
  • Total Assets -6.22%
Company report

Augment Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Augment Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Augment Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Apparao Satyam Whole-Time Director 06 Apr 2017 Current
Veeraveni Baddireddi Managing Director 06 Apr 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jul 2017 Past
Pramod Abcsdd Director 01 Jul 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Augment Therapeutics.

Augment Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 30.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.39%.

Augment Therapeutics revenue growth over time
Augment Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -6.22%
*******
*******
*******
*******
Profit or Loss
*******
 -30.37%
*******
*******
*******
*******
Net Worth
*******
 -10.39%
*******
*******
*******
*******
EBITDA
*******
 -38.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Augment Therapeutics?

Unlock access to Augment Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Augment Therapeutics?

Unlock and access historical data on people associated with Augment Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Augment Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Augment Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Augment Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Augment Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Augment Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Apparao Satyam was appointed as a Whole-time director was appointed as a Whole-time director on 06 Apr 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Director Appointment

    Progress on Veeraveni Baddireddi was appointed as a Managing Director was appointed as a Managing Director on 06 Apr 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Company Incorporation

    Progress on Augment Therapeutics Private Limited was registered on 06 Apr 2017 with Roc Hyderabad & aged 8 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Augment Therapeutics Private Limited?

The CIN of Augment Therapeutics Private Limited is U74999TG2017PTC116352.

Where is Augment Therapeutics Private Limited headquartered?

Augment Therapeutics Private Limited is headquartered at Villa No. 03, Greenspace Emerald, Puppalguda Bh Sri Mahalaxmi Temple, Puppalguda-Nars, Ingi Rd, Hyderabad, Telangana, 500089.

When was Augment Therapeutics Private Limited incorporated?

Augment Therapeutics Private Limited was incorporated on 06 April 2017.

Who are the current directors of Augment Therapeutics Private Limited?

The current directors of Augment Therapeutics Private Limited are

What is the primary industry of Augment Therapeutics Private Limited?

The primary industry of Augment Therapeutics Private Limited is Pharma.

Is Augment Therapeutics Private Limited a listed company?

Augment Therapeutics Private Limited is unlisted.

What is the capital structure of Augment Therapeutics Private Limited?

The authorized capital of Augment Therapeutics Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Augment Therapeutics Private Limited?

The compliance status of Augment Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available